Epidermal growth factor receptor (EGFR) inhibitor-induced dermal toxicity treated with topical application of a novel Staphylococcus epidermidis compound.
Authors: Mary C. Spellman, Travis C. Whitfill
Published: 2025-05-28
DOI:
10.1200/jco.2025.43.16_suppl.tps12149
Source:
Full article
Abstract
TPS12149